Scientists grow human metaphase kidneys in pigs for the first time
- Japan Second Round of Nuclear Contaminated Water Discharge Set to Commence
- Johns Hopkins University: Early Plasma Therapy Reduces Long COVID Risk
- Ketogenic Diet Linked to Heart Diseases and Cancers
- TROP2 ADC for Breast Cancer Succeeded In Phase III Clinical Trials
- Lead Poisoning’s More Serious Impacts on Health and IQ
- Startling Link Between Alcohol and Alzheimer’s Disease
Scientists grow human metaphase kidneys in pigs for the first time
- Nearly 300 People Food Poisoning in Japanese 130-Year Restaurant
- FDA’s First Potential TIL Therapy Review Delayed: How to Understand FDA’s “Resource Constraints”?
- A Chinese Doctor Accused of Accepting Bribes Totaling US$166 Million
- Nuclear contaminated water: Japanese government paid bribes and corrected the IAEA report
- Top 20 Companies of Instruments and Medical Equipment In The World
- The first DMD gene therapy SRP-9001 may cost 4 million US dollars
- How long can the patient live after heart stent surgery?
Scientists grow human metaphase kidneys in pigs for the first time.
On Sep 07, “Cell-Stem Cell” published a new study, showing that they successfully cultivated human-derived metaphase kidneys in pigs.
This is the first report in the world of humanized functional organ heterogeneity In vivo cultivation case.
According to Lai Liangxue, a researcher at the Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, the serious shortage of donor organs has limited the widespread clinical application of organ transplantation, and the in vivo cultivation of xenogeneic organs based on stem cells may be an ideal way to solve this problem in the future.
“The humanized organs obtained through this approach will not only have more comprehensive cell types and more perfect organ structure and function, but also because the donor cells come from the patient’s own body, it will effectively avoid the existence of xenogeneic or allogeneic organ transplantation. immune rejection and other issues.” Lai Liang said.
Previously, there were many technical obstacles in the realization of heterogeneous in vivo cultivation of humanized organs, which led to the failure of the idea of cultivating human organs from pigs.
In this study, a new human induced pluripotent stem cell with high differentiation potential, strong competition and anti-apoptosis ability was used, combined with an optimized embryo compensation technology system, to realize the xenogeneic in vivo cultivation of humanized mesonephros in a kidney-deficient pig model.
In the study, the aforementioned human-derived cells were injected into pig embryos, which were then transplanted into surrogate pigs.
The pig model used was genetically modified to lack genes needed for kidney development, leaving room for transplanted human cells.
The study strictly complied with relevant ethical regulations and international practices, and the pregnancy of surrogate pigs was terminated within 3 to 4 weeks of pig gestational age.
A total of 2 mesonephric chimeric pig embryos with a gestational age of 25 days and 3 mesonephric chimeric pig embryos with a gestational age of 28 days were obtained. Mesonephros means that the kidneys in the body have developed into mesonephros, the second stage of kidney development.
Immunofluorescent staining for key functional genes in kidney development proved that human donor cells had differentiated into functional cells expressing these genes, indicating that human donor cells in pig fetuses would be able to support human Kidney generation.
The researchers stated that this achievement proved for the first time the feasibility of cultivating humanized functional parenchymal organs in xenogeneic large animals based on stem cell and embryo compensation technology, which is a key step for the use of organ defect large animal models for organ xenogeneic in vivo cultivation The first step is of great significance to solving the severe shortage of donor organs.
Scientists grow human metaphase kidneys in pigs for the first time
(source:internet, reference only)
Disclaimer of medicaltrend.org
